GlassScriptPhysician profile
Matthew R Evans
NPI 1083812838
$37,316.48
in general payments reported to CMS, 2019-2025
25 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,075 · 2020: $1,259 · 2021: $311 · 2022: $1,890 · 2023: $2,505 · 2024: $13K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $5,865 · Travel and Lodging: $5,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,600.00 |
| Food and Beverage | $5,865.47 |
| Travel and Lodging | $5,316.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $10,911.02 | 2024-2025 | Selectra, Amvia Edge, Biomonitor |
| Irhythm Technologies, INC. | $9,275.00 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $9,093.19 | 2019-2025 | Aveir, Ensite, Amplatzer Amulet |
| Medtronic Vascular, INC. | $3,799.07 | 2019-2020 | |
| Cardiva Medical, INC. | $1,101.84 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biosense Webster, INC. | $994.35 | 2019-2025 | Carto 3, Qdot Micro Catheter, Na |
| Boston Scientific Corporation | $738.88 | 2023-2025 | Farapulse, General - Therapies, Apollo Esg System |
| Impulse Dynamics (USA) INC. | $226.54 | 2024-2025 | Optimizer |
| Sanofi-Aventis U.S. LLC | $167.81 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $136.46 | 2022-2023 | Camzyos |
| Medtronic, INC. | $125.45 | 2021-2024 | Pulseselect, Linq II |
| Regeneron Pharmaceuticals, INC. | $122.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $118.94 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.46 | 2020-2025 | Lifevest |
| Pfizer INC. | $86.85 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $86.75 | 2023-2024 | Impella |
| Atricure, INC. | $49.06 | 2019 | |
| Cordis US Corp. | $32.58 | 2025 | Mynx Control Venous |
| Edwards Lifesciences Corporation | $28.37 | 2024 | Sapien 3 Ultra Resilia |
| Ethicon US, LLC | $24.17 | 2023 | Harmonic, Ethicon |
| Actelion Pharmaceuticals US, INC. | $20.46 | 2024 | Uptravi, Opsumit |
| Pacira Therapeutics, INC. | $17.75 | 2019 | |
| Cook Medical LLC | $15.61 | 2022 | |
| Philips North America LLC | $13.90 | 2025 | Ecc Solutions |
| Convatec INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.